The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. 10x Genomics Inc shares valued at $77,540 were sold by Saxonov Serge on May 22 ’25. At $8.30 per share, Saxonov Serge sold 9,343 shares. The insider’s holdings dropped to 1,083,625 shares worth approximately $14.1 million following the completion of this transaction.
Also, Hindson Benjamin J. sold 7,485 shares, netting a total of over 62,120 in proceeds. Following the sale of shares at $8.30 each, the insider now holds 448,374 shares.
Before that, Taich Adam had sold 4,044 shares from its account. In a trade valued at $33,562, the Chief Financial Officer traded 10x Genomics Inc shares for $8.30 each. Upon closing the transaction, the insider’s holdings decreased to 4,044 shares, worth approximately $4.31 million.
As published in a research note from Leerink Partners on February 13, 2025, 10x Genomics Inc [TXG] has been rated down from an Outperform to a Market perform and the price target has been revised to $12 from $25. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early September. As of July 22, 2024, Jefferies has increased its “Hold” rating to a “Buy” for TXG. Earlier on July 18, 2024, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for TXG stock which previously was a “an Overweight”.
Analyzing TXG Stock Performance
On last trading session,, 10x Genomics Inc [NASDAQ: TXG] rose 7.88% to $13.01. The stock’s lowest price that day was $11.9, but it reached a high of $13.055 in the same session. During the last five days, there has been a surge of approximately 11.58%. Over the course of the year, 10x Genomics Inc shares have dropped approximately -33.11%. Shares of the company reached a 52-week high of $17.25 on 01/13/25 and a 52-week low of $6.78 on 04/07/25.
Support And Resistance Levels for 10x Genomics Inc (TXG)
According to the 24-hour chart, there is a support level at 12.26, which, if violated, would cause prices to drop to 11.50. In the upper region, resistance lies at 13.41. The next price resistance is at 13.81. RSI (Relative Strength Index) is 77.05 on the 14-day chart, showing overbought technical sentiment.
Is 10x Genomics Inc subject to short interest?
Stocks of 10x Genomics Inc saw a sharp steep in short interest on 2025-06-13 dropping by -1.44 million shares to 13.43 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 14.88 million shares. A decline of -10.74% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.59 of the overall float, the days-to-cover ratio (short ratio) decline to 3.59.
Which companies own the most shares of 10x Genomics Inc (TXG)?
In terms of 10x Genomics Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 107.3% from the previous closing price of $12.06. Analysts anticipate 10x Genomics Inc stock to reach 46 by 2025, with the lowest price target being 24. In spite of this, 8 analysts ranked 10x Genomics Inc stock as Hold at the end of 2025. On July 10, 2024, Deutsche Bank assigned a price target of “a Hold” to the stock and downgraded coverage with a $25.
